Lv7
5000 积分 2024-07-07 加入
High-fidelity AaCas12bMax enables the development of an engineered T cell therapy with enhanced safety and functional fitness
3个月前
已完结
A single-chain variable fragment-anticancer lytic peptide (scFv-ACLP) fusion protein for targeted cancer treatment
4个月前
已完结
Cetuximab scFv-modified 5-FU Loaded Chitosan Nanoparticles: A Novel Therapeutic Platform
4个月前
已完结
Development of bifunctional anti-PD-L1 antibody MMAE conjugate with cytotoxicity and immunostimulation
4个月前
已完结
Exploiting the Receptor-Binding Domains of R-Spondin 1 to Target Leucine-Rich Repeat-Containin G-Coupled Protein Receptor 5-Expressing Stem Cells in Ovarian Cancer
7个月前
已完结
Development and Characterization of a Lysosome-Targeting SLC3A2/PD-L1 Bispecific Antibody–Drug Conjugate for Enhanced Antitumor Efficacy in Solid Tumors
8个月前
已完结
Mining the CRBN target space redefines rules for molecular glue–induced neosubstrate recognition
9个月前
已完结
皖公网安备34019202002308
